Source: FDA, National Drug Code (US) Revision Year: 2026
Zidesamtinib is a kinase inhibitor. The molecular formula for zidesamtinib is C22H22FN7O and the molecular weight is 419.46 Daltons. The chemical name is (R)3-Ethyl-16-fluoro-10-methyl-19-methyl-20-oxa 3,4,9,10,11,23-hexaazapentacyclo[19.3.1.02,6.08,12.013,18]pentacosa-1(24),2(6),4,8,11,13,15,17,21(25),22- decaen-22-ylamine. The chemical structure of zidesamtinib is as follows:
Zidesamtinib is a white to tan powder with a pKa of 4.89. The aqueous solubility of zidesamtinib at 37°C is pH dependent, decreasing from 25 mg/mL at pH 2.5 to less than 0.1 mg/mL at pH 7.9. The log of the distribution coefficient (octanol/water) at pH 7.4 is 3.01.
JIDEYTRO (zidesamtinib) tablets for oral use are supplied as 25 mg and 100 mg dosage strengths. JIDEYTRO tablets, 25 mg are film-coated, oblong, pink tablets, debossed with "25" on one side and "ZDS" on the other side of the tablet. JIDEYTRO tablets, 100 mg are film-coated, oblong, yellow tablets, debossed with "100" on one side and "ZDS" on the other side of the tablet. Inactive ingredients in the tablet core are hydroxypropyl cellulose, magnesium stearate, mannitol, microcrystalline cellulose and sodium starch glycolate.
| Dosage Forms and Strengths |
|---|
|
Tablets 25 mg: pink, oblong, film-coated, debossed with "25" on one side and "ZDS" on the other side. Tablets 100 mg: yellow, oblong, film-coated, debossed with "100" on one side and "ZDS" on the other side. |
| How Supplied | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
JIDEYTRO (zidesamtinib) is supplied as follows:
Distributed by: Nuvalent Inc., Cambridge MA 02142 USA |
| Drug | Countries | |
|---|---|---|
| JIDEYTRO | United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.